Metabolism navigates neural cell fate in development, aging and neurodegeneration
Open Access
- 1 August 2021
- journal article
- review article
- Published by The Company of Biologists in Disease Models & Mechanisms
- Vol. 14 (8)
- https://doi.org/10.1242/dmm.048993
Abstract
An uninterrupted energy supply is critical for the optimal functioning of all our organs, and in this regard the human brain is particularly energy dependent. The study of energy metabolic pathways is a major focus within neuroscience research, which is supported by genetic defects in the oxidative phosphorylation mechanism often contributing towards neurodevelopmental disorders and changes in glucose metabolism presenting as a hallmark feature in age-dependent neurodegenerative disorders. However, as recent studies have illuminated roles of cellular metabolism that span far beyond mere energetics, it would be valuable to first comprehend the physiological involvement of metabolic pathways in neural cell fate and function, and to subsequently reconstruct their impact on diseases of the brain. In this Review, we first discuss recent evidence that implies metabolism as a master regulator of cell identity during neural development. Additionally, we examine the cell type-dependent metabolic states present in the adult brain. As metabolic states have been studied extensively as crucial regulators of malignant transformation in cancer, we reveal how knowledge gained from the field of cancer has aided our understanding in how metabolism likewise controls neural fate determination and stability by directly wiring into the cellular epigenetic landscape. We further summarize research pertaining to the interplay between metabolic alterations and neurodevelopmental and psychiatric disorders, and expose how an improved understanding of metabolic cell fate control might assist in the development of new concepts to combat age-dependent neurodegenerative diseases, particularly Alzheimer's disease.Keywords
Funding Information
- European Research Council (ERC-STG-2019-852086)
- Horizon 2020 (H2020-MSCA-IF-2017-797205)
- BrightFocus Foundation
- National Institute on Aging (K99-AG056679)
- Chen Foundation
- Austrian Science Fund (FWF-I5057, DK-W1206)
- Marshallplan-Jubiläumsstiftung
This publication has 185 references indexed in Scilit:
- Identification of Altered Metabolic Pathways in Plasma and CSF in Mild Cognitive Impairment and Alzheimer’s Disease Using MetabolomicsPLOS ONE, 2013
- Metabolic Plasticity in Stem Cell Homeostasis and DifferentiationCell Stem Cell, 2012
- TOR Signaling and Rapamycin Influence Longevity by Regulating SKN-1/Nrf and DAF-16/FoxOCell Metabolism, 2012
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not AnticipateCancer Cell, 2012
- Progress in understanding 2‐hydroxyglutaric aciduriasJournal of Inherited Metabolic Disease, 2012
- Acetyl-CoA Induces Cell Growth and Proliferation by Promoting the Acetylation of Histones at Growth GenesMolecular Cell, 2011
- Metabolic Imbalance Associated with Methylation Dysregulation and Oxidative Damage in Children with AutismJournal of Autism and Developmental Disorders, 2011
- Oncometabolite 2-Hydroxyglutarate Is a Competitive Inhibitor of α-Ketoglutarate-Dependent DioxygenasesCancer Cell, 2011
- Transgenic Mouse Models of Alzheimer's DiseaseMount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2010
- Mitochondria in Neuroplasticity and Neurological DisordersNeuron, 2008